30.09.2008 Amgen Receives Executive Summary from Independent Cochrane Collaboration Review of ESAs in Oncology

24.09.2008 Cell Therapeutics Regains Compliance with NASDAQ's Minimum Bid Price Requirement

23.09.2008 Genentech Announces October 14 Webcast of Financial and Other Business Results

22.09.2008 Amgen to Present at UBS Global Life Sciences Conference

22.09.2008 FDA Meeting Provides Green Light for Cell Therapeutics Submission of Supplemental Filing for Zevalin(R) Label Expansion

15.09.2008 Denosumab Osteoporosis Trial Finds Patients Transitioned from Alendronate (Fosamax(R)) to Denosumab Achieved Significantly Greater Gains in Bone Mineral Density versus Those Continuing on Alendronate

15.09.2008 Biovitrum to Acquire Kepivance(R) and Stemgen(R) and Exclusively License Kineret(R) from Amgen

12.09.2008 Anavex completes successful preclinical studies on lead Alzheimer's drug candidate

11.09.2008 Amgen to Present Important Clinical Trial Data at Two Key Congresses

06.09.2008 CTI Receives NASDAQ Letter

05.09.2008 ACADIA Pharmaceuticals Files Registration Statement as Required by Previously Announced Committed Equity Financing Facility